Pre-loaded capsular tension ring

Colin Kerr

Posted: Monday, April 1, 2019

OPHTEC has been granted CFDA approval for the pre-loaded capsular tension ring (CTR) “Ringject” in China.
CTRs were originally introduced to strengthen the zonule in eyes with zonular dehiscence (ZD) in cataract and lens surgery. They also prevent capsular phimosis in eyes at risk for postoperative capsular shrinkage.
“The main indication for the use of CTRs is still the management of ZD but we see surgeons using CTRs for other purposes too,” said Tiago Guerreiro, Global Marketing Director at OPHTEC BV. “We see a clear trend in the use of the pre-loaded Ringject with multifocal IOLs. It started a few years ago in Europe and other countries are following as surgeons see the advantages of (multifocal) IOL stabilisation in the capsular bag,” Mr Guerreiro continued. “We foresee a significant growth on the pre-loaded CTRs demand in China as the product offers easy handling. The CFDA approval of Ringject is another step forward on OPHTEC’s commitment to the Chinese ophthalmic community.”